CSIMarket

Company Name or Ticker Symbol

Search for oher Categories

Healthcare Sector

Biotechnology & Drugs Industry Profitability

Profitability by Company within Biotechnology & Drugs Industry
Company	Quarter	Gross Margin	Net Margin	Cash flow Margin	ROE
Avalanche Biotechnologies, Inc.	0 Q	-	-	-	-
Abbvie Inc.	3 Q	77.72 %	33.35 %	54.25 %	1285.47 %
Arca Biopharma, Inc.	3 Q	-	-	-	-
American Bio Medica Corp	3 Q	41.46 %	-	-	-
Achieve Life Sciences, Inc.	3 Q	-	-	-	-
Acorda Therapeutics Inc	3 Q	82.22 %	-	-	-
Aclaris Therapeutics, Inc.	3 Q	26.72 %	-	-	-
Actavis Plc	0 Q	-	-	-	-
Ocata Therapeutics, Inc.	0 Q	-	-	-	-
Adaptimmune Therapeutics Plc	3 Q	-	12.85 %	-	-
Fennec Pharmaceuticals Inc.	0 Q	-	-	-	-
Adma Biologics, Inc.	3 Q	-	-	-	-
Adverum Biotechnologies, Inc.	3 Q	-	-	-	-
Aerie Pharmaceuticals Inc	3 Q	97.19 %	-	-	-
Agenus Inc	3 Q	-	-	-	-
Allergan Plc	3 Q	84.74 %	-	-	3.24 %
Applied Genetic Technologies Corp	3 Q	-	8.55 %	-	-
Akers Biosciences, Inc.	3 Q	14.47 %	-	-	-
Alder Biopharmaceuticals Inc	3 Q	-	-	-	-
Alliance Bioenergy Plus, Inc.	2 Q	-	-	-	-
Allena Pharmaceuticals, Inc.	3 Q	-	-	-	-
Amarillo Biosciences Inc	3 Q	-	-	-	-
Amarantus Bioscience Holdings, Inc.	0 Q	-	-	-	-
Amarantus Bioscience Holdings, Inc.	0 Q	-	-	-	-
Amgen Inc.	3 Q	82.44 %	31.49 %	30.91 %	12.56 %
Albany Molecular Research Inc	2 Q	23.83 %	-	4.07 %	-
Amyris, Inc.	3 Q	42.32 %	-	-	-
Alpha Network Alliance Ventures Inc.	2 Q	32.18 %	-	-	-
Aeolus Pharmaceuticals, Inc.	2 Q	-	-	-	-
Ampliphi Biosciences Corp	3 Q	-	-	-	-
Aptose Biosciences Inc.	3 Q	-	-	-	-
Aptevo Therapeutics Inc.	3 Q	58.16 %	-	-	-
Ariad Pharmaceuticals Inc	0 Q	-	-	-	-
Arno Therapeutics, Inc	0 Q	-	-	-	-
Aerpio Pharmaceuticals, Inc.	3 Q	-	61.3 %	0.13 %	23.2 %
Artelo Biosciences, Inc.	4 Q	-	-	-	-
Assembly Biosciences, Inc.	3 Q	-	-	-	-
Asterias Biotherapeutics, Inc.	3 Q	50.86 %	-	-	-
Atara Biotherapeutics, Inc.	3 Q	-	-	-	-
Kubota Pharmaceutical Holdings Co Ltd	0 Q	-	-	-	-
Aviragen Therapeutics, Inc.	4 Q	-	-	-	-
Anavex Life Sciences Corp.	3 Q	-	-	-	-
Axim Biotechnologies, Inc.	3 Q	48.99 %	-	-	-
Axovant Sciences Ltd.	3 Q	-	-	-	-
Aytu Bioscience, Inc	3 Q	71.3 %	-	-	-
Azurrx Biopharma, Inc.	3 Q	-	-	-	-
Brainstorm Cell Therapeutics Inc.	3 Q	-	-	-	-
Biocryst Pharmaceuticals Inc	3 Q	-	-	-	-
Beesfree, Inc.	0 Q	-	-	-	-
Bg Medicine, Inc.	0 Q	-	-	-	-
U.s. Stem Cell, Inc.	3 Q	63.8 %	-	-	-
Premier Biomedical Inc	2 Q	16.07 %	-	-	-
Biogen Inc.	3 Q	86.6 %	41.96 %	33.2 %	25.55 %
Immucor Inc	0 Q	-	-	-	-
Bluebird Bio, Inc.	3 Q	99.75 %	-	-	-
Mj Biotech, Inc.	3 Q	-	-	-	-
Bionovo Inc	0 Q	-	-	-	-
Audentes Therapeutics, Inc.	3 Q	-	-	-	-
Bohai Pharmaceuticals Group, Inc.	0 Q	-	-	-	-
Vaxart, Inc.	3 Q	-	-	-	-
Biopharmx Corp	2 Q	45.83 %	-	-	-
Organicell Regenerative Medicine, Inc.	3 Q	73 %	-	13.81 %	-
Biorestorative Therapies, Inc.	3 Q	-	-	-	-
Boston Therapeutics, Inc.	3 Q	-	-	-	-
Biotime Inc	3 Q	96.44 %	-	-	-
Burzynski Research Institute Inc	4 Q	-	-	-	-
Cadence Pharmaceuticals Inc	0 Q	-	-	-	-
Cannis, Inc..	4 Q	-	-	-	-
Capricor Therapeutics, Inc.	3 Q	-	-	-	3.9 %
Capstone Therapeutics Corp.	3 Q	-	-	-	-
Casi Pharmaceuticals, Inc.	3 Q	-	-	-	12.67 %
Catalyst Biosciences, Inc.	3 Q	-	-	-	-
Cellular Biomedicine Group, Inc.	3 Q	46.78 %	-	-	-
China Botanic Pharmaceutical	0 Q	-	-	-	-
China Biologic Products Holdings, Inc.	4 Q	66.11 %	22.2 %	9.6 %	12.38 %
Cellcyte Genetics Corp.	0 Q	-	-	-	-
Cidara Therapeutics, Inc.	3 Q	-	-	-	-
Chromadex Corp.	3 Q	53.71 %	-	-	-
Cardax, Inc.	3 Q	56.3 %	-	-	-
Cen Biotech Inc	3 Q	-	-	-	-
Cerecor Inc.	3 Q	23.65 %	-	-	-
Compugen Ltd	2 Q	96.5 %	-	-	-
Coherus Biosciences, Inc.	3 Q	-	-	-	-
Chelsea Therapeutics International, Ltd.	0 Q	-	-	-	-
China Kangtai Cactus Bio-tech, Inc.	0 Q	-	-	-	-
Celladon Corporation	0 Q	-	-	-	-
Celldex Therapeutics, Inc.	3 Q	-	-	-	-
Cell Medx Corp.	4 Q	-	-	-	-
United Cannabis Corp	3 Q	26.51 %	-	-	-
Cannabics Pharmaceuticals Inc.	3 Q	-	-	-	-
Compass Biotechnologies Inc.	0 Q	-	-	-	-
Cohbar, Inc.	4 Q	-	-	-	-
Cocrystal Pharma, Inc.	3 Q	-	-	-	0.4 %
Core Lithium Corp.	3 Q	-	-	-	-
Cannapharmarx, Inc.	3 Q	-	-	-	-
Curis Inc	3 Q	-	-	-	-
Crispr Therapeutics Ag	3 Q	-	-	-	-
American Cryostem Corp	3 Q	94.33 %	-	-	-
Champions Oncology, Inc.	3 Q	48.44 %	3.99 %	-	2.24 %
Ctd Holdings Inc	3 Q	-	-	-	-
Cellceutix Corp	1 Q	-	-	-	-
Cytomx Therapeutics, Inc.	3 Q	-	-	-	-
Citius Pharmaceuticals, Inc.	3 Q	-	-	-	-
Neuralstem, Inc.	3 Q	-	-	-	-
Cel Sci Corp	3 Q	-	-	-	-
Cv Sciences, Inc.	3 Q	73.12 %	24.23 %	-	32.22 %
Cyanotech Corp	3 Q	32.86 %	-	-	-
Cytodyn Inc.	4 Q	-	-	-	-
Cytrx Corp	3 Q	-	-	-	-
Dare Bioscience, Inc.	3 Q	-	-	-	-
Dandrit Biotech Usa, Inc.	4 Q	-	-	-	-
Diadexus, Inc.	0 Q	-	-	-	-
Diffusion Pharmaceuticals Inc.	3 Q	-	-	-	-
Delmar Pharmaceuticals, Inc.	2 Q	-	-	-	-
Dimension Therapeutics, Inc.	3 Q	-	-	-	-
Dna Testing Centers Corp	4 Q	-	-	6.74 %	-
Dendreon Corp	0 Q	-	-	-	-
Noho, Inc.	0 Q	-	-	-	-
Windtree Therapeutics Inc	0 Q	-	-	-	-
Ds Healthcare Group, Inc.	2 Q	58.96 %	-	-	-
Emergent Biosolutions Inc.	3 Q	57.83 %	12.06 %	85.87 %	10.83 %
Edge Therapeutics, Inc.	3 Q	-	-	-	-
Eiger Biopharmaceuticals, Inc.	3 Q	-	-	-	-
Empowered Products, Inc.	0 Q	-	-	-	-
Endonovo Therapeutics, Inc.	3 Q	79.76 %	-	-	-
Entremed Inc	0 Q	-	-	-	-
Entest Group, Inc.	3 Q	-	-	-	0 %
Enumeral Biomedical Holdings, Inc.	3 Q	-	-	-	-
Enzon Pharmaceuticals, Inc.	3 Q	-	-	-	-
Enzymotec Ltd.	0 Q	-	-	-	-
Entia Biosciences, Inc.	4 Q	77.99 %	-	-	-
Eastgate Biotech Corp	2 Q	50.28 %	-	34.44 %	-
Fate Therapeutics Inc	3 Q	-	-	-	-
Fennec Pharmaceuticals Inc.	3 Q	-	-	-	-
Fulgent Genetics, Inc.	3 Q	53.56 %	-	85.96 %	-
Foamix Pharmaceuticals Ltd.	3 Q	-	-	-	154.59 %
Global Future City Holding Inc.	1 Q	64.93 %	-	-	-
Galena Biopharma, Inc.	3 Q	-	-	-	-
Genetic Technologies Ltd	2 Q	-	-	-	-
Gentium S.p.a.	0 Q	-	-	-	-
Synageva Biopharma Corp	0 Q	-	-	-	-
Gilead Sciences Inc	3 Q	80.59 %	37.51 %	23.86 %	7.55 %
Glucose Health, Inc.	3 Q	96.68 %	78.92 %	-	-
Genocea Biosciences, Inc.	2 Q	-	-	-	-
Aevi Genomic Medicine, Inc.	2 Q	-	-	-	-
Green Planet Bio Engineering Co. Ltd.	3 Q	-	-	-	-
Optec International, Inc.	3 Q	71.14 %	-	3.06 %	-
Guided Therapeutics Inc	3 Q	-	-	-	-
Genethera Inc	1 Q	-	-	-	-
G1 Therapeutics, Inc.	3 Q	-	-	-	-
Gtx Inc	3 Q	-	-	-	-
Gtx Corp	3 Q	76.51 %	-	-	-
Green Vision Biotechnology Corp.	1 Q	29.6 %	-	-	-
Halozyme Therapeutics Inc.	3 Q	97.55 %	-	-	18.87 %
Hubei Minkang Pharmaceutical Ltd.	0 Q	-	-	-	-
Health Discovery Corp	0 Q	-	-	-	-
Hemispherx Biopharma Inc	3 Q	-	-	-	-
Hedgepath Pharmaceuticals, Inc.	3 Q	-	-	-	-
Hyperion Therapeutics Inc	0 Q	-	-	-	-
Heska Corp	3 Q	47.79 %	-	-	1.23 %
Hst Global, Inc.	1 Q	-	-	-	-
Idera Pharmaceuticals, Inc.	3 Q	-	-	-	-
Igi Laboratories, Inc	0 Q	-	-	-	-
Intelgenx Technologies Corp.	3 Q	-	-	-	-
Intellect Neurosciences, Inc.	0 Q	-	-	-	-
Conversion Labs, Inc.	1 Q	77.87 %	39.84 %	5.51 %	120.74 %
Immage Biotherapeutics Corp.	0 Q	-	-	-	-
Immunomedics Inc	3 Q	-	-	-	-
Immune Therapeutics, Inc.	3 Q	-	-	-	-
Integrated Biopharma Inc	3 Q	11.83 %	1.54 %	1.33 %	-
Infinity Pharmaceuticals, Inc.	3 Q	-	60.82 %	-	-
Artemis Therapeutics, Inc.	3 Q	-	-	-	-
Innovus Pharmaceuticals, Inc.	3 Q	79.18 %	-	-	-
Iovance Biotherapeutics, Inc.	3 Q	-	-	-	-
Renovacare, Inc.	2 Q	-	-	-	-
Jounce Therapeutics,Â inc.	3 Q	-	-	-	-
Juno Therapeutics, Inc.	4 Q	-	-	-	-
Cadus Corp	1 Q	-	-	-	-
Kite Pharma, Inc.	2 Q	-	-	-	-
Krystal Biotech, Inc.	3 Q	-	-	-	-
Lion Biotechnologies, Inc.	1 Q	-	-	-	-
Lescarden Inc	0 Q	-	-	-	-
Atyr Pharma Inc	3 Q	-	-	-	-
Lixte Biotechnology Holdings, Inc.	3 Q	-	-	-	-
La Jolla Pharmaceutical Co	3 Q	92.62 %	-	-	-
Lightlake Therapeutics Inc.	0 Q	-	-	-	-
Lazuriton Nano Biotechnology (u.s.a.) Inc.	3 Q	-	-	-	-
Apollo Endosurgery,Â inc.	3 Q	63.66 %	-	-	-
Mateon Therapeutics Inc	0 Q	-	-	-	-
Mabvax Therapeutics Holdings, Inc.	3 Q	80.38 %	8.52 %	5.63 %	-
Multicell Technologies, Inc.	0 Q	-	-	-	-
Microchannel Technologies Corp	4 Q	-	-	-	-
Medgenics, Inc.	0 Q	-	-	-	-
Manhattan Pharmaceuticals Inc	0 Q	-	-	-	-
Mirna Therapeutics, Inc.	2 Q	-	-	-	-
Micromet, Inc.	0 Q	-	-	-	-
Mj Pharmaceuticals Inc.	0 Q	-	-	-	-
Cure Pharmaceutical Holding Corp.	3 Q	52.24 %	22.62 %	-	-
Momenta Pharmaceuticals Inc	3 Q	-	-	-	-
Mount Tam Biotechnologies, Inc.	3 Q	-	-	-	-
Marina Biotech, Inc.	2 Q	-	-	-	-
Myriad Genetics Inc	3 Q	79.09 %	-	-	5 %
Mymetics Corp	3 Q	-	-	-	-
Myokardia Inc	3 Q	-	-	-	-
Myrexis, Inc.	0 Q	-	-	-	-
Navidea Biopharmaceuticals, Inc.	3 Q	83.54 %	-	-	-
Nascent Biotech Inc.	3 Q	-	-	-	-
Neurocrine Biosciences Inc	3 Q	98.98 %	33.45 %	-	2.54 %
Caladrius Biosciences, Inc.	3 Q	-	-	-	-
Northsight Capital, Inc.	3 Q	-	-	-	-
Neogen Corp	4 Q	46.72 %	14.99 %	4.07 %	11.45 %
Nexus Biopharma Inc	0 Q	-	-	-	-
Nantkwest, Inc.	3 Q	-	-	-	-
Nile Therapeutics, Inc.	0 Q	-	-	-	-
Biovie Inc.	1 Q	-	-	-	-
Nutra Pharma Corp.	3 Q	14.91 %	-	-	-
Nanostring Technologies Inc	3 Q	67.53 %	-	-	-
Intellia Therapeutics, Inc.	3 Q	-	-	-	-
Nbty Inc	0 Q	-	-	-	-
Nugene International, Inc.	0 Q	-	-	-	-
Nutrastar International Inc.	0 Q	-	-	-	-
Novavax Inc	3 Q	-	-	-	-
N-viro International Corporation	0 Q	-	-	-	-
Novus Therapeutics, Inc.	3 Q	-	-	-	-
Nymox Pharmaceutical Corporation	3 Q	-	-	-	-
Obalon Therapeutics Inc	3 Q	52.53 %	-	-	-
Oncbiomune Pharmaceuticals, Inc	3 Q	-	-	-	-
Oncocyte Corp	3 Q	-	-	-	-
Spark Therapeutics, Inc.	3 Q	97.03 %	-	-	42.39 %
Outlook Therapeutics, Inc.	3 Q	-	-	-	-
Organovo Holdings, Inc.	3 Q	86.74 %	-	-	-
Ophthalix, Inc.	3 Q	-	-	-	-
Opiant Pharmaceuticals, Inc.	3 Q	-	-	-	-
Avant Diagnostics, Inc.	0 Q	-	-	-	-
Orgenesis Inc.	3 Q	45.73 %	68.54 %	-	139.1 %
Osiris Therapeutics, Inc.	3 Q	73.12 %	11.53 %	-	15.79 %
Oncovista Innovative Therapies, Inc	0 Q	-	-	-	-
Oxford Immunotec Global Plc	3 Q	71.51 %	-	-	-
Mateon Therapeutics Inc	3 Q	-	-	-	-
Gt Biopharma, Inc.	3 Q	-	-	-	-
Prolor Biotech, Inc.	0 Q	-	-	-	-
Procyon Corp	3 Q	72.1 %	8 %	16.39 %	-
Pdl Biopharma, Inc.	3 Q	82.44 %	37.64 %	7.85 %	-
Quint Media Inc.	0 Q	-	-	-	-
Petvivo Holdings, Inc.	1 Q	-	-	-	-
Protokinetix, Inc.	3 Q	-	-	-	-
Pulse Biosciences, Inc.	3 Q	-	-	-	-
Protalix Biotherapeutics, Inc.	3 Q	-	-	-	-
Pharmacyte Biotech, Inc.	3 Q	-	-	-	-
Propanc Biopharma, Inc.	3 Q	-	-	-	-
Proteon Therapeutics Inc	3 Q	-	-	-	-
Pluristem Therapeutics Inc	3 Q	-	-	-	-
Proteo Inc	3 Q	-	-	-	-
Protagonist Therapeutics, Inc	3 Q	-	-	-	-
Proteostasis Therapeutics, Inc.	3 Q	-	-	-	-
Pulmatrix, Inc.	3 Q	-	-	-	-
Pivot Pharmaceuticals Inc.	3 Q	-	-	-	-
Q Biomed Inc.	3 Q	-	-	-	-
Quidel Corp	3 Q	59.32 %	9.22 %	0.02 %	11.14 %
Qiagen Nv	0 Q	-	-	-	-
Quest Patent Research Corp	3 Q	-	-	-	-
Qrons Inc.	3 Q	-	-	-	-
Quotient Ltd	3 Q	27.13 %	-	-	-
Quint Media Inc.	0 Q	-	-	-	-
Rasna Therapeutics Inc.	4 Q	-	-	-	31.73 %
Rich Pharmaceuticals, Inc.	1 Q	50 %	-	1.02 %	-
Regenocell Therapeutics, Inc.	0 Q	-	-	-	-
Receptos, Inc.	0 Q	-	-	-	-
Ridgefield Acquisition Corp	3 Q	-	-	-	-
Restorgenex Corp	0 Q	-	-	-	-
Regen Biopharma Inc	3 Q	-	-	-	-
Regado Biosciences Inc	0 Q	-	-	-	-
Repligen Corp	3 Q	55.21 %	9.68 %	-	3.87 %
Regenxbio Inc.	3 Q	90.26 %	-	-	16.51 %
Regenerx Biopharmaceuticals Inc	3 Q	-	-	-	-
Relmada Therapeutics, Inc.	3 Q	-	-	-	-
Repros Therapeutics Inc.	3 Q	-	-	-	-
Respirerx Pharmaceuticals Inc.	3 Q	-	-	-	-
Aytu Bioscience, Inc.	0 Q	-	-	-	-
Ruthigen, Inc.	0 Q	-	-	-	-
Radient Pharmaceuticals Corp	0 Q	-	-	-	-
Strongbridge Biopharma Plc	3 Q	73.05 %	-	-	-
Sangui Biotech International Inc	3 Q	99.35 %	-	-	-
Seattle Genetics Inc	3 Q	92.71 %	-	-	-
Sangamo Therapeutics, Inc	3 Q	-	-	-	-
Shengtai Pharmaceutical, Inc.	0 Q	-	-	-	-
Skinovation Pharmaceutical Inc	3 Q	-	-	-	-
Skinvisible Inc	3 Q	80.99 %	-	30.87 %	-
Sun Biopharma, Inc.	3 Q	-	-	-	-
Syndax Pharmaceuticals Inc	3 Q	-	-	-	-
Soligenix, Inc.	3 Q	10.43 %	-	-	-
Sienna Biopharmaceuticals, Inc.	3 Q	-	-	-	-
Senesco Technologies Inc	0 Q	-	-	-	-
Senesco Technologies Inc	0 Q	-	-	-	-
Microbot Medical Inc.	2 Q	-	-	-	-
Spotlight Innovation Inc.	2 Q	32.93 %	-	-	-
Sunwin Stevia International, Inc.	0 Q	-	-	-	-
Intellicell Biosciences, Inc.	0 Q	-	-	-	-
Savient Pharmaceuticals Inc	0 Q	-	-	-	-
Sevion Therapeutics, Inc.	3 Q	-	-	-	-
Tobira Therapeutics, Inc.	0 Q	-	-	-	-
Tracon Pharmaceuticals, Inc.	3 Q	-	-	-	-
Bio-techne Corp	3 Q	66.03 %	10.68 %	-	12.03 %
Telik Inc	0 Q	-	-	-	-
Mabvax Therapeutics Holdings, Inc.	0 Q	-	-	-	-
Tongli Pharmaceuticals (usa), Inc.	0 Q	-	-	-	-
Tg Therapeutics, Inc.	3 Q	-	-	-	-
Tg Therapeutics, Inc.	0 Q	-	-	-	-
Twinlab Consolidated Holdings, Inc.	3 Q	8.08 %	-	0.07 %	-
Teligent, Inc.	2 Q	29.44 %	-	-	-
True Nature Holding, Inc.	3 Q	-	-	-	-
Targeted Medical Pharma, Inc.	0 Q	-	-	-	-
Targacept Inc	0 Q	-	-	-	-
Tribus Enterprises, Inc.	3 Q	-	-	-	-
Trovagene, Inc.	3 Q	69.81 %	-	-	-
Therapeutic Solutions International, Inc.	3 Q	83.04 %	-	-	-
Trius Therapeutics Inc	0 Q	-	-	-	-
Taxus Pharmaceuticals Holdings, Inc.	1 Q	-	-	-	-
Tyme Technologies, Inc.	1 Q	-	-	-	-
Uluru Inc.	3 Q	-	-	-	-
United Bancshares Inc	0 Q	-	-	-	-
Vitality Biopharma, Inc.	3 Q	59.71 %	-	-	-
Vericel Corp	3 Q	63.81 %	-	-	-
Vical Inc	3 Q	-	-	-	-
Meridian Bioscience Inc	3 Q	60.55 %	-	3.45 %	-
Volitionrx Ltd	3 Q	-	-	-	-
Viropharma Inc	0 Q	-	-	-	-
Vermillion, Inc.	3 Q	-	-	-	-
Vistagen Therapeutics, Inc.	3 Q	-	-	-	-
Vistagen Therapeutics, Inc.	1 Q	-	-	-	-
Ventrus Biosciences Inc	0 Q	-	-	-	-
Voyager Therapeutics, Inc.	3 Q	-	-	-	-
Warner Chilcott Plc	0 Q	-	-	-	-
Windtree Therapeutics Inc	3 Q	-	-	-	-
Weikang Bio-technology Group Co., Inc.	0 Q	-	-	-	-
Wave Life Sciences Ltd.	3 Q	-	-	-	-
Xenetic Biosciences, Inc.	3 Q	-	-	-	-
Acceleron Pharma Inc	3 Q	-	-	-	-
Xstelos Holdings, Inc.	0 Q	-	-	-	-
Vilacto Bio Inc.	3 Q	31.05 %	-	-	-

Profitability

Biotechnology & Drugs Industry
Gross margin contracted to 80.45 % in the 4. Quarter 2018 from 80.71 % in previous quarter, now Ranking #8 and ranking within sector #1.
Net margin for Biotechnology & Drugs Industry is 19.74 % above industry average.

More on Biotechnology & Drugs Industry Profitability

Biotechnology & Drugs Industry achieved cash flow margin of 25.69 % and above average return on equity of 6.29 %

More on Biotechnology & Drugs Industry Cash flow
More on Biotechnology & Drugs Industry ROE

• Cash Flow Margin

Financial Strength

Mgmt. Effectiveness

Cardiovascular Segment
Revenues		Income
-4.17%	1.93%	100.11%	371.2%
Y/Y	Q/Q	Y/Y	Q/Q

Neuroscience Segment
Revenues		Income
-4.17%	1.93%	100.11%	371.2%
Y/Y	Q/Q	Y/Y	Q/Q

Anti-Infective Segment
Revenues		Income
14.75%	-7.45%	23.14%	-12.12%
Y/Y	Q/Q	Y/Y	Q/Q

Respiratory Segment
Revenues		Income
-4.17%	1.93%	100.11%	371.2%
Y/Y	Q/Q	Y/Y	Q/Q

Tweet
Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar LOGC's Profile Stock Price LOGC's Financials Business Description Fundamentals Charts & Quotes LOGC's News Suppliers LOGC's Competitors Customers & Markets Economic Indicators LOGC's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. Free Stock Market News Feeds

Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071